Rabbit IgG anti-Rat IgG (F(ab)2)-FITC, MinX none

Catalog Number: DNA-SEC-182614
Article Name: Rabbit IgG anti-Rat IgG (F(ab)2)-FITC, MinX none
Biozol Catalog Number: DNA-SEC-182614
Supplier Catalog Number: SEC-182614
Alternative Catalog Number: DNA-SEC-182614
Manufacturer: dianova
Host: Rabbit
Category: Antikörper
Application: FLISA,FACS,IF
Species Reactivity: Rat
Immunogen: Rat IgG F(ab)2 fragment
Conjugation: FITC
Alternative Names: rabbit anti-Rat IgG F(ab)2 fluorescein Conjugated Antibody, rabbit anti-Rat IgG Fab2 fragment FITC Conjugated Antibody
Format: IgG
Target Specificity: IgG (F(ab')2)
Cross-Adsorption (MinX): no cross-adsorbtion
Anti-Rat IgG F(ab)2 Antibody generated in rabbit recognizes the dimeric Fab portion of the rat IgG molecule. Rat IgG F(ab)2 is a proteolytic fragment of immunoglobulin G (IgG) obtained by limited digestion with the enzyme pepsin under controlled conditio
Clonality: Polyclonal
Concentration: 10.0 mg/mL
Isotype: Ig
Buffer: 0.01 M Sodium Phosphate, 0.15 M Sodium Chloride, pH 7.2
Purity: This product is an IgG fraction antibody purified from monospecific antiserum by a multi-step process which includes delipidation, salt fractionation and ion exchange chromatography followed by extensive dialysis against the buffer stated above.  Assay by immunoelectrophoresis resulted in a single precipitin arc against anti-fluorescein, anti-Rabbit Serum, Rat IgG, Rat IgG F(ab’)2 and Rat Serum.  No reaction was observed against Rat IgG F(c).
Form: Lyophilized
Formula: 10 mM NaPO4,150 mM NaCl,pH 7,2,lyophilisate,0,01% Thimerosal
Target: Rat
Antibody Type: Secondary Antibody
Application Dilute: FLISA Dilution: 1:10,000 - 1:50,000, Flow Cytometry Dilution: 1:500 - 1:2,500, Fluorochrome Protein Value: 2.5, IF Microscopy Dilution: 1:1,000 - 1:5,000
Application Notes: This product is designed for immunofluorescence microscopy, fluorescence based plate assays (FLISA) and fluorescent western blotting. This product is also suitable for multiplex analysis, including multicolor imaging, utilizing various commercial platforms.